Andreae-Noris Zahn AG
- WKN: 504700
- ISIN: DE0005047005
- Land: Deutschland
Nachricht vom 20.08.2009 | 15:00
Andreae-Noris Zahn AG: Veröffentlichung gemäß § 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
Andreae-Noris Zahn AG / Veröffentlichung einer Mitteilung nach § 21
Abs. 1 WpHG (Aktie)
Veröffentlichung einer Stimmrechtsmitteilung, übermittelt durch die DGAP -
ein Unternehmen der EquityStory AG.
Für den Inhalt der Mitteilung ist der Emittent verantwortlich.
---------------------------------------------------------------------------
We have received the following Voting Rights Notifications pursuant to
sections 21 para 1, 22 para 1 sentence 1 no 1 Securities Trading Act
(Wertpapierhandelsgesetz, 'WpHG'):
1. Hereby we, KKR European Co-Invest Fund I L.P. (Cayman), George Town,
Grand Cayman, Cayman Islands, are notifying pursuant to section 21 para 1
WpHG that we exceeded the thresholds of 3%, 5%, 10%, 15%, 20% and 25% of
the voting rights in Andreae-Noris Zahn Aktiengesellschaft, 60486 Frankfurt
am Main on 25 March 2008. Our voting portion amounts to 29.99%. This
corresponds to 3,202,754 votes.
All of the aforementioned voting rights are attributed to us pursuant to
section 22 para 1 sentence 1 no 1 WpHG via our controlled undertakings: AB
Acquisitions Holdings Limited, Alliance Boots GmbH, AB Acquisition Luxco 1
S.à r.l., Alliance Boots Limited (formerly known as AB Acquisitions UK
Topco 1 Limited), AB Acquisitions UK Topco 2 Limited, AB Acquisitions UK
Holdco 1 Limited, AB Acquisitions Limited, Alliance Boots Holdings Limited
(formerly known as Alliance Boots Limited, formerly known as Alliance Boots
plc), Alliance Unichem Limited (formerly known as Alliance Unichem plc),
Alliance Unichem Group Limited, Ivor Shipley Limited and Unichem
Healthcare Netherlands B.V.
This portion comprises 19,00 % (corresponding to 2,028,900 voting rights)
held by Ivor Shiply Limited directly and 10.99% (corresponding to 1,173,854
voting rights) held by Unichem Healthcare Netherlands B.V. directly.
2. Hereby we, KKR MIF Carry Holdings L.P. (Cayman), George Town, Grand
Cayman, Cayman Islands, are notifying pursuant to section 21 para 1 WpHG
that we exceeded the thresholds of 3%, 5%, 10%, 15%, 20% and 25% of the
voting rights in Andreae-Noris Zahn Aktiengesellschaft, 60486 Frankfurt am
Main, on 25 March 2008. Our voting portion amounts to 29.99%. This
corresponds to 3,202,754 votes.
All of the aforementioned voting rights are attributed to us pursuant to
section 22 para 1 sentence 1 no 1 WpHG via our controlled undertakings: KKR
European Co-Invest Fund I L.P., AB Acquisitions Holdings Limited, Alliance
Boots GmbH, AB Acquisition Luxco 1 S.à r.l., Alliance Boots Limited
(formerly known as AB Acquisitions UK Topco 1 Limited), AB Acquisitions UK
Topco 2 Limited, AB Acquisitions UK Holdco 1 Limited, AB Acquisitions
Limited, Alliance Boots Holdings Limited (formerly known as Alliance Boots
Limited, formerly known as Alliance Boots plc), Alliance Unichem Limited
(formerly known as Alliance Unichem plc), Alliance Unichem Group Limited,
Ivor Shipley Limited and Unichem Healthcare Netherlands B.V.
This portion comprises 19,00 % (corresponding to 2,028,900 voting rights)
held by Ivor Shiply Limited directly and 10.99% (corresponding to 1,173,854
voting rights) held by Unichem Healthcare Netherlands B.V. directly.
3. Hereby we, KKR MIF Carry Limited (Cayman), George Town, Grand Cayman,
Cayman Islands, are notifying pursuant to section 21 para 1 WpHG that we
exceeded the thresholds of 3%, 5%, 10%, 15%, 20% and 25% of the voting
rights in Andreae-Noris Zahn Aktiengesellschaft, 60486 Frankfurt am Main,
on 25 March 2008. Our voting portion amounts to 29.99%. This corresponds to
3,202,754 votes.
All of the aforementioned voting rights are attributed to us pursuant to
section 22 para 1 sentence 1 no 1 WpHG via our controlled undertakings: KKR
MIF Carry Holdings L.P. (Cayman), KKR European Co-Invest Fund I L.P., AB
Acquisitions Holdings Limited, Alliance Boots GmbH, AB Acquisition Luxco 1
S.à r.l., Alliance Boots Limited (formerly known as AB Acquisitions UK
Topco 1 Limited), AB Acquisitions UK Topco 2 Limited, AB Acquisitions UK
Holdco 1 Limited, AB Acquisitions Limited, Alliance Boots Holdings Limited
(formerly known as Alliance Boots Limited, formerly known as Alliance Boots
plc), Alliance Unichem Limited (formerly known as Alliance Unichem plc),
Alliance Unichem Group Limited, Ivor Shipley Limited and Unichem
Healthcare Netherlands B.V.
This portion comprises 19,00 % (corresponding to 2,028,900 voting rights)
held by Ivor Shiply Limited directly and 10.99% (corresponding to 1,173,854
voting rights) held by Unichem Healthcare Netherlands B.V. directly.
4. Hereby we, KKR Index Fund Investments L.P. (Cayman), George Town, Grand
Cayman, Cayman Islands, are notifying pursuant to section 21 para 1 WpHG
that we exceeded the thresholds of 3%, 5%, 10%, 15%, 20% and 25% of the
voting rights in Andreae-Noris Zahn Aktiengesellschaft, 60486 Frankfurt am
Main, on 25 March 2008. Our voting portion amounts to 29.99%. This
corresponds to 3,202,754 votes.
All of the aforementioned voting rights are attributed to us pursuant to
section 22 para 1 sentence 1 no 1 WpHG via our controlled undertakings: KKR
MIF Carry Limited (Cayman), KKR MIF Carry Holdings L.P. (Cayman), KKR
European Co-Invest Fund I L.P., AB Acquisitions Holdings Limited, Alliance
Boots GmbH, AB Acquisition Luxco 1 S.à r.l., Alliance Boots Limited
(formerly known as AB Acquisitions UK Topco 1 Limited), AB Acquisitions UK
Topco 2 Limited, AB Acquisitions UK Holdco 1 Limited, AB Acquisitions
Limited, Alliance Boots Holdings Limited (formerly known as Alliance Boots
Limited, formerly known as Alliance Boots plc), Alliance Unichem Limited
(formerly known as Alliance Unichem plc), Alliance Unichem Group Limited,
Ivor Shipley Limited and Unichem Healthcare Netherlands B.V.
This portion comprises 19,00 % (corresponding to 2,028,900 voting rights)
held by Ivor Shiply Limited directly and 10.99% (corresponding to 1,173,854
voting rights) held by Unichem Healthcare Netherlands B.V. directly.
5. Hereby we, KKR IFI GP L.P. (Cayman), George Town, Grand Cayman, Cayman
Islands, are notifying pursuant to section 21 para 1 WpHG that we exceeded
the thresholds of 3%, 5%, 10%, 15%, 20% and 25% of the voting rights in
Andreae-Noris Zahn Aktiengesellschaft, 60486 Frankfurt am Main, on 25 March
2008. Our voting portion amounts to 29.99%. This corresponds to 3,202,754
votes.
All of the aforementioned voting rights are attributed to us pursuant to
section 22 para 1 sentence 1 no 1 WpHG via our controlled undertakings: KKR
Index Fund Investments L.P. (Cayman), KKR MIF Carry Limited (Cayman), KKR
MIF Carry Holdings L.P. (Cayman), KKR European Co-Invest Fund I L.P., AB
Acquisitions Holdings Limited, Alliance Boots GmbH, AB Acquisition Luxco 1
S.à r.l., Alliance Boots Limited (formerly known as AB Acquisitions UK
Topco 1 Limited), AB Acquisitions UK Topco 2 Limited, AB Acquisitions UK
Holdco 1 Limited, AB Acquisitions Limited, Alliance Boots Holdings Limited
(formerly known as Alliance Boots Limited, formerly known as Alliance Boots
plc), Alliance Unichem Limited (formerly known as Alliance Unichem plc),
Alliance Unichem Group Limited, Ivor Shipley Limited and Unichem
Healthcare Netherlands B.V.
This portion comprises 19,00 % (corresponding to 2,028,900 voting rights)
held by Ivor Shiply Limited directly and 10.99% (corresponding to 1,173,854
voting rights) held by Unichem Healthcare Netherlands B.V. directly.
6. Hereby we, KKR IFI Limited (Cayman), George Town, Grand Cayman, Cayman
Islands, are notifying pursuant to section 21 para 1 WpHG that we exceeded
the thresholds of 3%, 5%, 10%, 15%, 20% and 25% of the voting rights in
Andreae-Noris Zahn Aktiengesellschaft, 60486 Frankfurt am Main, on 25 March
2008. Our voting portion amounts to 29.99%. This corresponds to 3,202,754
votes.
All of the aforementioned voting rights are attributed to us pursuant to
section 22 para 1 sentence 1 no 1 WpHG via our controlled undertakings: KKR
IFI GP L.P. (Cayman), KKR Index Fund Investments L.P. (Cayman), KKR MIF
Carry Limited (Cayman), KKR MIF Carry Holdings L.P. (Cayman), KKR European
Co-Invest Fund I L.P., AB Acquisitions Holdings Limited, Alliance Boots
GmbH, AB Acquisition Luxco 1 S.à r.l., Alliance Boots Limited (formerly
known as AB Acquisitions UK Topco 1 Limited), AB Acquisitions UK Topco 2
Limited, AB Acquisitions UK Holdco 1 Limited, AB Acquisitions Limited,
Alliance Boots Holdings Limited (formerly known as Alliance Boots Limited,
formerly known as Alliance Boots plc), Alliance Unichem Limited (formerly
known as Alliance Unichem plc), Alliance Unichem Group Limited, Ivor
Shipley Limited and Unichem Healthcare Netherlands B.V.
This portion comprises 19,00 % (corresponding to 2,028,900 voting rights)
held by Ivor Shiply Limited directly and 10.99% (corresponding to 1,173,854
voting rights) held by Unichem Healthcare Netherlands B.V. directly.
20.08.2009 Finanznachrichten übermittelt durch die DGAP
---------------------------------------------------------------------------
Sprache: Deutsch
Emittent: Andreae-Noris Zahn AG
Solmsstraße 25
60486 Frankfurt am Main
Deutschland
Internet: www.anzag.de
Ende der Mitteilung DGAP News-Service
---------------------------------------------------------------------------
Interaktiv
Weitere News
-
07.11.11 14:10
Andreae-Noris Zahn AG: Bekanntmachung gemäß § ... -
23.08.11 15:07
Andreae-Noris Zahn Aktiengesellschaft: Bekannt ... -
05.08.11 11:00
Andreae-Noris Zahn AG: Bekanntmachung gemäß § ... -
22.06.11 11:00
Andreae-Noris Zahn AG: Bekanntmachung gemäß § ... -
26.05.11 12:25
Andreae-Noris Zahn AG: Voraussichtliches Konze ...
Interview im Fokus
DATAGROUP AG: Übernahme mit viel Potenzial
Mit der Übernahme der Consinto GmbH, eines mittelständischen IT-Beratungshauses mit SAP-Kompetenz, ist der DATAGROUP AG ein weiterer entscheidender Schritt auf dem Weg zum Full-Services-IT-Dienstleister gelungen. CEO Max H.-H. Schaber spricht im Interview mit financial.de von einem „exzellenten“ Wertsteigerungspotenzial für die Aktionäre.
GBC-Analyse im Fokus
GBC-Management-Interview: MPH Mittelständische Pharma Holding AG
Die MPH Mittelständische Pharma Holding AG, ein Spezialist für Generika und Parallelimporte, hatte in den vergangenen Quartalen stets die Fortsetzung der erfolgreichen Geschäftsentwicklung präsentieren können. GBC-Analyst Cosmin Filker hat anlässlich der in Kürze anstehenden Berichtssaison ein Interview mit dem MPH-Vorstand, Dr. Christian Pahl, geführt.
Bewertungsfazit: Für Anleger bedeutet das jetzige Kursniveau eine attraktive Opportunität am starken Wachstum zu partizipieren, bei gleichzeitig defensivem Geschäftsmodell und attraktiver Dividendenrendite (2011e: 7,6 %).
Der AKTIONÄR News

04. Februar 10:00 EADS: Noch deutlich Luft nach oben
04. Februar 09:45 Gildemeister: Feuer frei!
04. Februar 08:00 Deutsche Bank und Commerzbank: Es hätte schlimmer kommen können
04. Februar 07:35 Euro/Australischer Dollar: Stark,stärker Aussie…
03. Februar 23:00 Rekorde an den US-Märkten beflügeln die Phantasie der Anleger